REGISTER
Beyond the CT Scan: Patient Navigation and the Future of Lung Cancer Care
After attending the 2026 Rescue Lung Society meeting in Boston, Prof. Chunxue Bai reflects on a question that connects patient navigation with China’s work in lung cancer screening: how can patients move reliably from an initial scan through assessment, care and follow-up? He proposes integrating navigation with AI and connected care, while identifying implementation and evaluation as the next steps.

By Prof. Chunxue Bai, Zhongshan Hospital, Fudan University

On October 16, 2026, I presented China’s work in lung cancer screening and pulmonary nodule management at the Rescue Lung Society (RLS) annual meeting in Boston. What stayed with me most, however, was a theme that ran through the meeting: patient navigation.

Article Key Points

• Prof. Chunxue Bai presented China’s approach to lung cancer screening and pulmonary nodule management in Boston.

• Patient navigation could help connect screening, diagnostic assessment, treatment and follow-up.

• Bai proposes combining navigation with AI and connected care, an approach that still requires evaluation.

What happens after the scan?

RLS held a patient navigation workshop on October 15. Discussions at the meeting also addressed screening pathways, follow-up, barriers to care and quality control. They prompted me to think beyond the accuracy of any single test.

A patient whose scan reveals a pulmonary nodule may need further imaging, risk assessment, a specialist consultation or continued surveillance. Each step raises practical questions: When should the next scan take place? Is another test needed? Who will explain the result and coordinate what follows?

Navigation means more than directing someone to the next appointment. It is a way to help patients move through an increasingly complex care pathway—from identifying people at high risk and conducting screening to evaluating findings, arranging appropriate care and reassessing patients over time.

China’s work in nodule management

In my presentation, “Lung Cancer Screening and Pulmonary Nodule Management in China,” I described the country’s substantial lung cancer burden and efforts to put screening and nodule management into routine practice.

The Chinese Alliance Against Lung Cancer has promoted screening and more standardized pulmonary nodule management through consensus documents, guidelines, research and a network of pulmonary nodule centers. The aim is to carry these approaches beyond publications and conference discussions into clinical pathways and primary care.

For me, the central challenge is a shift from looking at a nodule to managing the person who has it. Greater diagnostic accuracy matters, but patients also need a clear plan for assessment and follow-up.

Where digital tools may fit

My team is exploring a model that brings together artificial intelligence, GPT-based tools, the Internet of Things and patient navigation. In that proposed model, AI could support nodule detection and risk assessment; GPT-based tools could bring together imaging findings, medical history, guidelines and follow-up information; connected systems could help link hospitals, primary care and patients at home.

Medical agents might eventually assist with reminders, education and coordination across the pathway. These are proposed uses, not evidence that the combined model improves clinical outcomes. The question is whether such tools can help create a reliable sequence of screening, assessment, diagnosis, treatment when needed, follow-up and reassessment.

From a meeting to a shared research agenda

The Boston meeting brought two areas of work into focus for me. RLS emphasized patient navigation and the practical delivery of CT lung screening. Our work in China has explored how digital tools might support screening and nodule management at scale.

I hope future collaboration between RLS and the Chinese Alliance Against Lung Cancer will examine screening databases, nodule management standards, navigation systems and AI applications. International multicenter real-world studies could help assess whether these approaches work across different healthcare settings.

The journey from Shanghai to Boston required considerable time away from clinical work. I returned with a clearer question for the next stage of research: how can we connect medical knowledge, technology and clinical services so that patients know what happens after the scan?

Expert Profile: Prof. Chunxue Bai

白春学教授_医生团队_内科_上海百汇医院- 百汇parkway

• Professor and Chief Physician, Department of Respiratory Medicine, Zhongshan Hospital, Fudan University

• Chair, Chinese Alliance Against Lung Cancer

• Director, Shanghai Respiratory Research Institute

• Director, Shanghai Clinical Quality Control Center for Respiratory Medicine

• Editor-in-Chief, Clinical eHealth

0
0
Loading